Thursday 30 July 2015

Soybean may trade upward on less monsoon forecast according to IMD

According to IMD, as of 28 July, monsoon rains in India were 3% below normal. It said rains in July and August could be less than normal. Kharif sowing progress - area of 14.30 million hectares were covered by oil seeds as of 24 July including 10.48 million hectares of Soybean crop. Soybean may consolidate sideways with a bullish bias.


Moneymaker Research PVT. LTD. Guide to all Investors, You can Sell NCDEX Soyabean for Long term targets 2900. you can hold it near at October month. 

Tuesday 21 July 2015

Why broken Sun Pharma shares, brokerage houses Also Reduced Target


Sun Pharma stock is seeing a huge drop in the morning. Shares of the company declined by 12 percent at Rs 833 has come. Market analysts say that Sun Pharma profit warning is issued for the current fiscal. Pressure on the company's stock. After the news, Sun Pharma giant brokerage houses also have slashed their target.

Why is Sun Pharma stock decline
Sun Pharma profit warning is issued for the current fiscal. The company says it will raise the cost of the merger of Ranbaxy, which may have put pressure on margins.On the margins may be pressured. Since fiscal year 2016 growth will improve. Consolidation in the coming years, while the company will break from business.

Sun Pharma Managing Director Dilip Sanghvi Analysts also said, "We will see the reality of adverse news that may come in the coming days to be ready to handle themselves Sanghvi Hoga. Akikrn process with the FDA issue 'Financial Year after 2016 'will have gone. He indicated that exposure to loss under the products prepared at the option of the other sites can be adopted.


Brokerage House deductible target

> Makwayri Sun Pharma, target reduced from Rs 1100 to Rs 1000 has been fixed. In the financial year 2016-17 EPS estimates by 15 per cent and 10 per cent cut.

> Bank of America Merrill Lynch downgraded Sun Pharma target of Rs 950 to Rs 1063 has been fixed. EPS estimates for the financial year 2016-17 and 20 per cent in the 30% cut.

> Barclays Ikwlvet on Sun Pharma has set a target of Rs 922 while maintaining the rating.

> Morgan Stanley's overweight rating on Sun Pharma reduced from Rs 1010 to Rs 1047 while maintaining the target is fixed.

> Jefrij purchase on the Sun Pharma has set a target of Rs 1100 while keeping opinion. According to him, raising concerns that delays in Halol plant.




Wednesday 15 July 2015

NCDEX Guarseed bearish On weak Export Demand @ Live Update By Moneymaker Financial Indore

Guarseed closed down more than 1 percent on tueday on receding Guargum export demand coupled with enough stocks in local mandies. However, sowing of Guarseed reported some drop due to limited rainfall. Guarseed might move lower to 4140 levels in coming sessions. Its currently trading around 4400.

Investment Advice for Long term and Intraday Investors
@ You can Sell NCDEX Guarseed near at 4450 to 4350 targets 4050 stop loss 4671.  

Share it